Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Closes Initial Share Purchase of Cannova Medical Ltd.

• Nabis Holdings has closed on its previously announced initial purchase of a 49 percent interest in Cannova Medical Ltd., with an option to purchase the remaining 51 percent
• The company selected Cannova Medical for its unique approach to consumable cannabis technology and untapped industry potential
• Nabis sees Cannova as a potential disruptor in the edible cannabis industry

Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company pursuing specialty investment opportunities in the burgeoning cannabis industry (among others), recently announced that it has now completed the purchase of a 49 percent interest in Cannova Medical Ltd., totaling 2,260,500 shares. Nabis retains the option to acquire the remaining 51 percent interest in Cannova.

Cannova Medical is a provider of innovative solutions for cannabis consumption. Pursuing its interest in investment across all vertically integrated aspects of the cannabis sector, with a focus on strategic revenue generation, Nabis selected Cannova because of its innovative take on consumable cannabis. In connection with this transaction, Nabis will have exclusive distribution rights in North America.

Cannova, based in Israel, is developing an alternative method for cannabis consumption in the form of a sublingual strip. The sublingual strips are infused with cannabis molecules that are produced using a patent-protected process involving the combination of various formulations with water soluble cannabinoids and natural active ingredients. The sublingual strip allows producers to more effectively control dosage quantities and significantly increases the effect of the cannabis, allowing it to be used for a variety of purposes, including pain management, as a concentration aid, as an antidepressant and to support better sleep.

Additionally, Cannova is developing the NovaJet Pro (“NovaJet”), an innovative printing machine that provides producers with the ability to create customized film strips, according to client demand, in real time. The NovaJet is expected to be able to assemble different quantities of cannabinoids and other natural substances, ultimately producing sublingual strips that are highly measured, accurate and tailored to specific demand.

Nabis CEO and Director Shay Shnet sees Cannova as a disruptor in the cannabis space as it relates to the way consumers view consumption (http://nnw.fm/9GsfP). “[Cannova’s] team has developed an innovative solution that largely appeals to consumers looking for convenience compared to current forms of consumption such as smoking, evaporation and ingestion of oil,” he said in a news release. “While we remain focused on our strategic plan for rapid expansion into limited-license states, we also pay close attention to companies that have the potential to disrupt the legal cannabis space. Cannova’s patent-protected solution allows the user to get a customized, personal combination of THC, CBD, and other active ingredients that meet[s] their personal, unique requirements in real time, thus changing the way cannabis is consumed.”

Shnet described Cannova’s product design as one that easily fits into the home of the average consumer, sitting on a countertop with a design akin to an average espresso or coffee machine while utilizing a “next-generation ability to combine various active ingredients.”

Looking to Nabis’s future with Cannova, Shnet spoke highly of the latter’s unique technology and its untapped industry potential. “We’re excited to team up with Nabis to provide cannabis users a safe, accurate and discrete way to consume cannabis,” he continued.

Cannova founder and CEO Omri Schanin indicated a promising future for Cannova with the assistance of Nabis. “The Nabis team, their experience and established network of cannabis-related portfolio, will help boost Cannova to become a cutting-edge leader in the space,” he added.

Utilizing Cannova’s innovative technology, Nabis is looking to disrupt the edibles sector and is well positioned to capitalize on the growing popularity of consumable cannabis.

For more information, visit the company’s website at www.NabisHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to NABIF are available in the company’s newsroom at http://nnw.fm/NABIF

About NetworkNewsWire 

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Trxade Group Inc.’s (TRXD) Fiscal 2019 Off to Record Start with Q1 Revenue of $1.5 Million

• TRXD sales grew to $1.5 million in Q1 2019; operating income also rose when compared to the same period of the prior year
• The company is adding new independent pharmacies and increasing pharmacy sales
• Mail-order pharmacy services and a newly launched mobile app offer lower prescription drug costs for U.S. consumers

Trxade Group Inc. (OTCQB: TRXD), an integrated pharmaceutical logistical services company that offers a web-based e-hub buying platform for transactions between independent pharmacists and drug manufacturers, reported record Q1 2019 revenues. The company also reported (http://nnw.fm/znW3v) higher operating income, as it sees “continuing revenue growth and profitability in 2019.”

TRXD reported Q1 2019 sales of $1.5 million, as compared to $852,923 in revenues for the same period of the previous year. Operating income grew in Q1 2019 to $171,759 from $98,728 in Q1 2018. Net income reached $125,229 for Q1 2019, as compared to $82,269 for the same period of the previous year.

“Our 2019 fiscal year is off to a record start and in line with our primary objective of expanding our membership base while simultaneously focusing on increasing their utilization rates,” Trxade Group chairman and CEO Suren Ajjarapu stated in a news release. “At the end of the first quarter, we reported record platform subscribers and transactional revenue along with higher net and operating profits for the same period.”

TRXD’s proprietary trading platform enables independent pharmacies to buy online, directly from national pharmaceutical suppliers. The company attributed its revenue growth to an increase in its fee income from this web-based supplier-to-pharmacy trading platform, as well as increased pharmaceutical sales from its wholly owned subsidiary, Community Specialty Pharmacy LLC.

“Our proprietary software trading platform at www.Trxade.com, which enables independent pharmacies to purchase drugs, is adding new members on a monthly basis and, as a result, enabling us to experience strong top and bottom line growth across the board,” Ajjarapu added. In Q1 2019, TRXD added more than 400 new independent pharmacies, which were successfully onboarded on to the Trxade software trading platform.

On the consumer side, TRXD operates a full-service, mail-order business with pharmacy, warehouse and drug-delivery services, along with a mobile app – www.Delivmeds.com – that enables home delivery. These B2C offerings lower drug costs for U.S. consumers, the company said, and directly challenge the inefficient value chain by providing drug-price transparency and efficient buying and delivery of drugs.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://nnw.fm/TRXD

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Readies for Canada’s Second Cannabis Wave with Successful Run of APP Extraction Process

• Sproutly is a licensed producer with exclusive rights to Infusion Biosciences’ groundbreaking Aqueous Phytorecovery Process (“APP”) technology for naturally water-soluble cannabinoids
• Deloitte estimates that Canada’s cannabis edibles and topicals market could be worth $2.7 billion annually
• The company has entered into an exclusive joint venture with Moosehead Breweries Limited to develop and produce nonalcoholic, cannabis-infused beverages

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) has reached another milestone by successfully completing the first run of the proprietary Aqueous Phytorecovery Process (“APP”) extraction technology licensed from Infusion Biosciences Inc., Sproutly CEO and Director Keith Dolo announced in a news release (http://nnw.fm/z0NRr).

“Sproutly has made significant progress towards building a world-class cannabis beverage and edibles company since going public in July of last year,” Dolo stated in the release. “The successful completion of our first run of the APP extraction technology in Canada marks a major milestone for our company and brings us another step forward in achieving our goal of becoming a leader in the cannabis infused product space.”

The initial APP run took place at Sproutly’s wholly owned Toronto Herbal Remedies Inc., an ACMPR-licensed facility designed and built for cultivating pharmaceutical-grade cannabis for the production and formulation of a natural, truly water-soluble cannabis solution. APP technology extracts water-soluble forms of cannabinoids (Infuz2O) and specific strains of oil-based cannabinoids (Bio Natural Oil), which were both successfully recovered during Sproutly’s first run of the proprietary technology.

“APP technology is a low-cost, gentle method to produce Infuz2O, a groundbreaking discovery that delivers the total effects of the strain of cannabis from which it is made; on-set effects start within approximately 5 minutes and dissipate within approximately 90 minutes,” Dolo stated in an earlier news release (http://nnw.fm/hhW2q).

Sproutly’s premium offering, Infuz2O, is described as “the world’s first and only truly water-soluble cannabis solution” for formulation into beverages. The Infuz2O water-soluble cannabinoids recovered during this first APP run are slated for product formulation and shelf-stability testing for fast-onset cannabis beverages under an exclusive joint venture with OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited (http://nnw.fm/b516U). APP technology is also used in the production of Bio Natural Oils, which deliver the full-spectrum of cannabinoids and terpenes of the strain from which they are made, thus empowering consumers to enjoy the experience of their strains of choice in an edible form (http://nnw.fm/lPD0b).

Deloitte estimates that Canada’s cannabis edibles and beverages sectors will bring $2.7 billion per year into a market that is expected to generate higher profits for retailers (http://nnw.fm/jI8Sp). Deloitte’s report, titled ‘Nurturing new growth: Canada gets ready for Cannabis 2.0’, indicates that the new legislation will likely attract consumers who have been reluctant to try traditional cannabis consumption methods.

Sproutly’s team is working diligently, developing and formulating fast-acting and long-lasting Infuz2O and Bio Natural Oil edible products for the Canadian market that meet Health Canada’s specialized regulations. A review of the final regulations for cannabis edibles, extracts and topical products, published on Lexology.com (http://nnw.fm/6JiXB), stated that, while the rules come into force on October 17, 2019, it will likely take until mid-December before consumers find the products on store shelves.

For more information, visit the company’s website at www.Sproutly.ca

NOTE TO INVESTORS: The latest news and updates relating to SRUTF are available in the company’s newsroom at http://nnw.fm/SRUTF

About NetworkNewsWire 

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Enhanced DehydraTECH Delivers More CBD into the Body

• The new version of the DehydraTECH delivery platform is suitable for use in pills, capsules and tablets for the pharmaceutical, medical and supplement markets
• DehydraTECH has demonstrated that it can deliver eight times more CBD into the blood than standard industry formulations
• Animal testing shows that combining DehydraTECH with a nanoemulsion formulation greatly assists delivery of cannabinoids and nicotine across the blood-brain barrier

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) new enhanced version of its patented delivery technology, DehydraTECH, has demonstrated that it can deliver eight-times more CBD into the blood and 19-times more CBD into the brain tissue than standard industry formulations. These results were confirmed in clinical lab tests conducted with live animals. LXRP has filed new patent applications based on these innovations (http://nnw.fm/bXV3l).

The new DehydraTECH delivery platform is ideally suited for solid-oral dosage forms such as capsules, pills and tablets for use by the pharmaceutical, medical and supplement markets.

LXRP intends to perform more studies on the enhanced DehydraTECH and focus on optimizing implementation regarding product applications for its licensees.

In earlier test results, LXRP announced that original or standard DehydraTECH combined with generic nanotech techniques delivers 1,137 percent more cannabidiol (CBD) into animal brain tissue following oral ingestion than certain existing industry formulations (http://nnw.fm/SU1sL). The tests consisted of oral administration of CBD into 10 male Sprague-Dawley rats.

In animal tests conducted in 2018 and 2019, results showed that DehydraTECH greatly assisted in the delivery of drugs, including nicotine and cannabinoids, across the blood-brain barrier. The demonstrated effectiveness of DehydraTECH, combined with nanoemulsification, significantly expands the application of the technology for conventional dosage forms, consumable liquids and beverage dosage forms.

LXRP is a Canadian bioscience company and a drug-delivery platform innovator. The company out-licenses its disruptive delivery technology, DehydraTECH. The technology is designed to promote healthier ingestion methods and lower overall dosing. Lexaria is the only company globally to have a patent issued for the oral delivery of all cannabinoids. DehydraTECH has received patents in the United States and Australia, and has multiple patents pending in more than 40 countries worldwide.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Did the Wild West Crypto Show Diss Facebook’s Libra Coin?

It’s been another wild week in the crypto space, as Facebook prepares to launch its global digital currency. News of the social media giant’s Libra Coin was the headline topic on episode 66 of the Wild West Crypto Show. Hosts Drew Taylor and Brent Bates didn’t quite know what to make of it, triple-tagging the cryptocurrency as good, bad and ugly. They’re not the only skeptics. Regulators, too, have doubts about Libra, as do its partners (http://nnw.fm/2Mk0I). Such straight shooting is typical of the Wild West Crypto Show (WWCS). From its home in Kerrville, Texas, the WWCS aims to both entertain and educate.

Libra seems to be aimed primarily at the over $600 billion in remittances that makes their way across international borders every year. The media company says that Libra would allow for the storage, delivery and transfer of such funds with minimal transaction fees. To administer the currency, FB plans to create a non-profit organization based in Switzerland. “Just as people can use their phones to message friends anywhere in the world today, with Libra, the same can be done with money — instantly, securely and at low cost,” the company has indicated (http://nnw.fm/zZx2Y).

The first segment of the WWCS featured Samson Williams. Williams is adviser, professor and keynote speaker for the upcoming Coinvention, scheduled for September 20-21, 2019, at the Loews Hotel in Philadelphia. He waxed enthusiastically about the confluence of cannabis, crypto and crowdfunding. As part of Coinvention, his organization will be conducting a masterclass in raising capital for cannabis enterprises using the new SEC pathway – Regulation Crowdfunding (Reg CF).

For his weekly update, Jonathan Keim, communications director of CryptCurrencyWire, zeroed in, first, on the Bitcoin.com makeover. Bitcoin.com is rebranding. The company has adopted a new logo, which it hopes will signal that its platform to buy and transfer cryptocurrencies offers a more equitable financial system.

Keim also talked about Celsius Network’s acquisition of BSave, which is expected “to provide 45,000 new crypto HODLers an easy way to learn crypto.” It’s a good matchup. Celsius is a cryptocurrency lending and borrowing platform, while BSave offers interest-bearing “deposit accounts” for bitcoin.

Last on his list was the launch of Wealthbase, a simulated trading game for individual investors. With Wealthbase, users can create, trade and track portfolios based on real-world securities. The platform could be a painless way for newbies to learn about investing.

For the latest episode, which includes CryptoCurrencyWire’s ongoing segment featuring the latest news from around the world, visit http://nnw.fm/3piQI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Celebrates Cannabis Shipment to 10th Canadian Province

• Organigram is in a sharp growth pattern as the company builds toward its production capacity target of 113,000 kilograms of cannabis per year at its New Brunswick campus
• The company’s recent announcement of Health Canada’s licensing approval for an additional 17 cultivation rooms brings total licensed target production capacity to 61,000 kg per year
• The company announced a shipment of product to Quebec in June, marking its official fulfillment of an order to the last of Canada’s 10 provinces and establishment of its coast-to-coast network
• Organigram is also refurbishing its Moncton Campus for its own edibles facility and additional in-house extraction capacity

According to its announcement on June 24, Organigram Holdings Inc. (NASDAQ: OGI) (TSX.V: OGI)received licensing approval for 17 cultivation rooms to complete licensing of the Phase 4A development of its Moncton Campus in New Brunswick (http://nnw.fm/f7Gnt) for total licensed target production capacity of 61,000 kg per year. By the end of the year, Organigram is expected to complete construction on Phase 4 expansion for total target production capacity of 113,000 kilograms per year, once fully licensed and operational(1).

The company is also refurbishing part of its facility at its Moncton Campus in order to pursue Phase 5 development of a cannabis edibles and derivatives facility and additional extraction capacity. The company has committed to invest C$15 million in a chocolate production line, with capacity of up to four million kilograms of chocolate cannabis edibles per year (http://nnw.fm/cMJu0).

Organigram began trading common shares on the Nasdaq in late May, uplisting from the OTCQX Best Market. One of only a handful of licensed producers operating in all of Canada’s provinces, the company celebrated the first shipment of its cannabis products to Quebec in June, marking official fulfillment of orders in all 10 provinces from coast to coast.

“Our national reach means brands such as Edison Cannabis Co. and Trailblazer are available across the country, offering a range of cannabis options for legal adult recreational cannabis consumers,” CEO Greg Engel stated in the news release announcing the shipment (http://nnw.fm/sZCA9). “As we look ahead to the legalization of edibles and extracts, we are excited to have the national network in place to offer Canadians access to new thinking and new products as they explore Cannabis 2.0, and a new cannabis experience.”

The company continues to build strategic partnerships as part of its focus on expanding globally, targeting international cannabidiol (CBD) product markets beyond Canada’s borders. In line with its strategy, the company generated positive adjusted EBITDA of C$13.3 million(2) in the second quarter of its fiscal year, marking positive adjusted EBITDA for the third consecutive quarter.

For more information, visit the company’s website at www.Organigram.ca

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://nnw.fm/OGRMF

(1) Several factors can cause actual capacity to differ. Please see the company’s latest MD&A and Annual Information Form.

(2) Adjusted EBITDA is a non-IFRS measure. Please see the company’s latest MD&A.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com